We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$426M
Cap. Flow
+$459M
Cap. Flow %
39.34%
Top 10 Hldgs %
6.63%
Holding
2,667
New
887
Increased
542
Reduced
345
Closed
877

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.6M
2
META icon
Meta Platforms (Facebook)
META
+$9.1M
3
MSFT icon
Microsoft
MSFT
+$8.07M
4
CVX icon
Chevron
CVX
+$5.32M
5
DECK icon
Deckers Outdoor
DECK
+$4.36M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.1M
2
GE icon
GE Aerospace
GE
+$3.43M
3
AZO icon
AutoZone
AZO
+$3.1M
4
MS icon
Morgan Stanley
MS
+$2.66M
5
BKR icon
Baker Hughes
BKR
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Industrials 14.87%
3 Healthcare 14.62%
4 Consumer Discretionary 13.4%
5 Financials 12.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBU icon
876
Caribou Biosciences
CRBU
$158M
$341K 0.03%
+208,162
New +$665K
ANAB icon
877
AnaptysBio
ANAB
$1.59B
$341K 0.03%
13,603
-2,101
-13% -$48.9K
ABM icon
878
ABM Industries
ABM
$2.84B
$340K 0.03%
6,732
+2,074
+45% +$96.7K
MGY icon
879
Magnolia Oil & Gas
MGY
$5.69B
$340K 0.03%
13,420
-3,269
-20% -$83.4K
XLV icon
880
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$339K 0.03%
2,328
+56
+2% +$8.03K
MRNA icon
881
Moderna
MRNA
$22.1B
$339K 0.03%
2,856
-13,243
-82% -$1.68M
ARQT icon
882
Arcutis Biotherapeutics
ARQT
$3.48B
$339K 0.03%
36,466
+25,793
+242% +$233K
FLO icon
883
Flowers Foods
FLO
$1.62B
$339K 0.03%
15,274
+3,251
+27% +$77K
AXS icon
884
AXIS Capital
AXS
$8.63B
$339K 0.03%
4,799
-1,166
-20% -$79.1K
PAY icon
885
Paymentus
PAY
$3.96B
$339K 0.03%
+17,841
New +$349K
BAX icon
886
Baxter International
BAX
$12.1B
$338K 0.03%
+10,113
New +$373K
EVTC icon
887
Evertec
EVTC
$1.88B
$338K 0.03%
+10,172
New +$368K
VTR icon
888
Ventas
VTR
$48.7B
$338K 0.03%
+6,597
New +$309K
BXC icon
889
BlueLinx
BXC
$453M
$336K 0.03%
3,607
-1,553
-30% -$165K
PLUS icon
890
ePlus
PLUS
$2.33B
$336K 0.03%
+4,556
New +$348K
FOX icon
891
Fox Class B
FOX
$21.3B
$335K 0.03%
+10,456
New +$316K
FHI icon
892
Federated Hermes
FHI
$4.5B
$334K 0.03%
10,169
-2,472
-20% -$82.9K
ALHC icon
893
Alignment Healthcare
ALHC
$3.86B
$334K 0.03%
42,749
-33,615
-44% -$219K
HMC icon
894
Honda
HMC
$37.8B
$332K 0.03%
+10,307
New +$349K
AORT icon
895
Artivion
AORT
$1.27B
$331K 0.03%
+12,916
New +$290K
SYM icon
896
Symbotic
SYM
$5.28B
$331K 0.03%
9,412
-1,473
-14% -$59.6K
ENV
897
DELISTED
ENVESTNET, INC.
ENV
$331K 0.03%
+5,283
New +$332K
PLTR icon
898
Palantir
PLTR
$315B
$330K 0.03%
+13,016
New +$293K
BOKF icon
899
BOK Financial
BOKF
$8.58B
$329K 0.03%
3,594
+912
+34% +$82.4K
NRIX icon
900
Nurix Therapeutics
NRIX
$2.43B
$328K 0.03%
15,729
-10,611
-40% -$165K

Similar funds

XTX Topco's Q2 2024 Portfolio in Review

As of Q2 2024, XTX Topco held 2,667 positions worth $1.17B, up 57% from $742M the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

XTX Topco deployed $459M of net new capital in Q2 2024, opening 887 new positions and adding to 542 existing holdings. Its largest new stake was RTX Corp: 40,074 shares worth $4.02M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was GE Aerospace, an estimated $3.43M trimmed.

  • XTX Topco's largest Q2 2024 buy was RTX Corp: 40,074 shares worth $4.02M.
  • XTX Topco added most to Apple in Q2 2024, an estimated $12.6M increase.
  • XTX Topco's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $3.43M.
  • XTX Topco fully exited Tesla in Q2 2024, selling an estimated $4.1M.
  • XTX Topco's ten largest holdings make up 6.6% of its $1.17B portfolio in Q2 2024.
  • XTX Topco opened 887 new positions and closed 877 in Q2 2024.
  • XTX Topco's portfolio value rose 57% quarter-over-quarter to $1.17B.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.